Literature DB >> 4297630

Factors modifying host resistance to viral infection. 3. Effect of whole body x-irradiation on experimental encephalomyocarditis virus infection in mice.

B R Murphy, L A Glasgow.   

Abstract

The resistance of mice to encephalomyocarditis (EMC) virus was markedly decreased by prior exposure to whole body X-irradiation. In contrast to non-irradiated controls, the course of EMC virus infection in X-irradiated animals was characterized by (a) an enhanced mortality, (b) shortening of the incubation period, (c) higher levels of virus in the blood during the viremic phase and persistence of the viremia until death, (d) failure to develop detectable serum levels of neutralizing antibody, and (e) the earlier appearance and higher levels of virus in brain and heart tissue. The level of interferon in the serum during the course of infection was similar in both groups. The administration of relatively small quantities of anti-EMC virus neutralizing antibody to X-irradiated mice during the early phases of the infection with EMC virus restored their resistance to levels comparable to nonirradiated animals. An alteration of local organ defense mechanisms in the central nervous system could not be demonstrated. It is proposed that (a) the inability of the X-irradiated animal to elaborate specific neutralizing antibody was a critical determinant in their failure to clear the viremia, (b) this increase in the level and duration of the viremic phase resulted in the exposure of target organs to a greater inoculum of virus, and (c) the enhanced mortality observed in irradiated mice reflected this greater target organ involvement. The experimental model presented, therefore, suggests that the immunologic response is a critical determinant of host resistance during this primary systemic virus infection.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4297630      PMCID: PMC2138485          DOI: 10.1084/jem.127.5.1035

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

Review 1.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

Review 2.  MECHANISM OF RECOVERY FROM VIRAL INFECTION.

Authors:  S BARON
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

3.  Virus-polysaccharide interactions. I. An agar polysaccharide determining plaque morphology of EMC virus.

Authors:  K K TAKEMOTO; H LIEBHABER
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

4.  Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice.

Authors:  K T BRUNNER; D HUREZ; R T McCLUSKEY; B BENACERRAF
Journal:  J Immunol       Date:  1960-07       Impact factor: 5.422

5.  Role of interferon during viremia. II. Protective action of circulating interferon.

Authors:  S Baron; C E Buckler; R M Friedman; R V McCloskey
Journal:  J Immunol       Date:  1966-01       Impact factor: 5.422

6.  Blood clearance of enteroviruses in the normal and immune rat.

Authors:  I Schultz
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

7.  Antibody formation. III. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs.

Authors:  J W UHR; M S FINKELSTEIN; J B BAUMANN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

8.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

9.  The role of antibody, delayed hypersensitivity, and interferon production in recovery of guinea pigs from primary infection with vaccinia virus.

Authors:  R M FRIEDMAN; C E BUCKLER; R I STEINMULLER
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

  9 in total
  21 in total

1.  Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.

Authors:  F Vlaspolder; C A Kraaijeveld; R van Buuren; M Harmsen; B J Benaissa-Trouw; H Snippe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.

Authors:  R A Fiske; P A Klein
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

3.  Factors Modifying Host Resistance to Virus Infection: II. Enhanced Susceptibility of Mice to Encephalomyocarditis Virus Infection During Pregnancy.

Authors:  P A Farber; L A Glasgow
Journal:  Am J Pathol       Date:  1968-09       Impact factor: 4.307

4.  Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.

Authors:  D A Stringfellow; L A Glasgow
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

5.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

6.  Effect of Corynebacterium acnes on interferon production in mouse peritoneal exudate cells.

Authors:  J Fischbach; L A Glasgow
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

7.  Differential susceptibility of male and female mice to encephalomyocarditis virus: effects of castration, adrenalectomy, and the administration of sex hormones.

Authors:  S B Friedman; L J Grota; L A Glasgow
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

8.  Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus.

Authors:  L H Perrin; D Reynolds; R Zinkernagel; M B Oldstone
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

9.  Tilorone hydrochloride: an oral interferon-inducing agent.

Authors:  D A Stringfellow; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

10.  Resistance to arbovirus challenge in mice immediately after vaccination.

Authors:  J Casals; S M Buckley; D W Barry
Journal:  Appl Microbiol       Date:  1973-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.